Rhythm Pharmaceuticals Stock Widgets and Gadgets
| RYTM Stock | USD 59.92 0.02 0.03% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- RYTM Rhythm Pharmaceuticals
- Latest Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide
- RYTM 59.92 -0.02
- Low 59.81
- High 63.08
- Volume 720.9 K
- Alpha 0.26
- Beta 2.06
- Return On Equity -1.48
- Return On Asset -0.46
- Profit Margin (2.30) %
- Operating Margin (1.32) %
- Current Valuation 3.39 B
- Shares Outstanding 61.46 M
- Shares Owned By Insiders 0.52 %
- Shares Owned By Institutions 99.48 %
- Number Of Shares Shorted 8.36 M
- Price To Book 328.47 X
- Price To Sales 32.74 X
- Revenue 77.43 M
- Gross Profit 21.5 M
- EBITDA (168.46 M)
- Net Income (184.68 M)
- Cash And Equivalents 235.6 M
- Cash Per Share 4.64 X
- Total Debt 1.26 M
- Debt To Equity 0.01 %
- Current Ratio 5.59 X
- Book Value Per Share 0.18 X
- Cash Flow From Operations (136.16 M)
- Short Ratio 27.30 X
- Earnings Per Share (4.32) X
- Price To Earnings To Growth 0.75 X
- Target Price 70.27
- Number Of Employees 226
- Beta 2.09
- Market Capitalization 3.68 B
- Total Asset 332.75 M
- Retained Earnings (894.74 M)
- Working Capital 253.06 M
- Net Asset 332.75 M
- Accumulation Distribution 37370.22
- Daily Balance Of Power (0.01)
- Rate Of Daily Change 1.0
- Day Median Price 61.45
- Day Typical Price 60.94
- Price Action Indicator (1.53)
- Period Momentum Indicator (0.02)
- Relative Strength Index 80.74
Market Snapshot Widget Example
DAX Index Germany | 19,405 0.43 | |
Taiwan Weighted Taiwan | 22,948 0.19 | |
PSI 20 Stock Portugal | 6,439 0.47 | |
CROBEX Croatia | 3,124 0.19 | |
Budapest SE Hungary | 79,472 0.1 | |
IDX 30 Jakarta Indonesia | 458.68 2.23 | |
ISEQ 20 Price Ireland | 1,615 0.28 | |
NYSE Comp USA | 20,220 0.48 | |
Tel Aviv 35 Israel | 2,281 0.93 | |
Coreshares Index Tracker South Afric | 1,100 0.09 | |
IPC MEXICO Mexico | 50,228 0.42 | |
KL Technology Malaysia | 60.32 1.96 | |
IBEX 35 Index Spain | 11,712 0.47 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,543 0.29 | |
SPASX Dividend Opportunities Australia | 1,697 0.26 | |
HNX 30 Vietnam | 471.74 0.81 | |
Bucharest BET-NG Romania | 1,213 0.53 | |
AMS Small Cap Netherlands | 1,188 0.40 | |
Oslo Exchange Mutual Norway | 1,426 0.25 | |
BEL Small Belgium | 8,148 0.53 | |
Basic Materials Brazil | 5,781 0.32 | |
Swiss Leader Price Switzerland | 1,933 0.06 | |
Fondo Mutuo ETF Chile | 1,368 0.41 | |
Athens General Comp Greece | 1,406 0.33 | |
Stock Exchange Of Thailand | 1,443 0.21 | |
PX Prague Stock Czech Repub | 1,697 0.37 | |
THE PHILIPPINE STOCK Philippines | 6,850 1.03 | |
WIG 30 Poland | 2,826 0.44 | |
BIST Electricity Turkey | 493.66 0.85 |
Investing Ideas
In addition to having Rhythm Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Rhythm Pharmaceuticals
Compare Rhythm Pharmaceuticals To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhythm Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.32) | Revenue Per Share 1.863 | Quarterly Revenue Growth 0.478 | Return On Assets (0.46) | Return On Equity (1.48) |
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.